why are glp 1 bad for you The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 What to Eat (and Limit)

Its important to continue regular follow-ups with your healthcare provider to ensure that the treatment is working effectively for your specific needs

Hydroxytrimethyllysine Aldolase (HTMLA) The next step involves the cleavage of HTML by HTMLA, a cytosolic enzyme that splits the molecule into 4-trimethylaminobutyraldehyde (TMABA) and glycine

In a statement following the EMA PRACs decision, Alison Cave, chief safety officer at the MHRA, said: We are currently reviewing safety data on the risk of suicidal thoughts and thoughts of self-harm associated with medicines known as GLP-1 receptor agonists, used for treating both type 2 diabetes and weight loss

Because these drugs can affect how treatment is tolerated and how well it works, your care team will weigh the potential risks and benefits before deciding whether to pause or continue a GLP-1 during cancer treatment